) The Cell and Molecular Biology Core provides essential services for the proposed Program Project. The capabilities of cellular and molecular biology have only recently been harnessed in our studies which focus on pathophysiological characteristics of solid tumors. We have thus assembled as part of our program, a team of supporting cellular and molecular biologists to assist us in the investigation of the relationships between solid tumor physiology and the expression of molecular determinants. The facilities and services of this important Core will provide on-site expertise, equipment, and assay protocols to our Project Leaders who are primarily biomedical engineers with relatively limited experience in molecular, cellular and morphological techniques. The molecular biology component of the Core will provide the expertise, apparatus, assay protocols, and essential reagents, for the characterization and location of gene expression and protein distribution. These routine services will include the isolation and purification of DNA, RNA and proteins, in situ hybridization, Southern, Northern and Western assays, the generation of DNA constructs, and the modification of tumor cell lines by transfection and genotypic characterization. The cell biology component will provide the expertise and services for cell culture (maintenance of tumor cell lines and genetically transfected cell lines, quality control, and maintenance of supplies). The morphology component will provide the expertise and routine services for histology and immunolabeling (providing equipment, supplies and protocols, fixation, embedding and sectioning of tissues, and staining using established immunohistochemical and immunocytochemical procedures). In addition to providing these services the Core personnel will interact with Project Investigators to provide strategic consultation in the design of experimental procedures, to introduce state-of-the-art techniques, and assist in the completion of experiments and interpretation of data for molecular, cell and morphology studies. In addition to providing these services the Core personnel will interact with Project Investigators to provide strategic consultation in the design of experimental procedures, to introduce state-of-the-art techniques, and assist in the completion of experiments and interpretation of data for molecular, cellular and morphologic studies. Finally, the Core personnel will assure reagent and antibody quality, manage biological information (e.g. DNA, protein sequences from Genbank), acquire and store research materials, and maintain essential logs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA080124-03
Application #
6649410
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-08-01
Project End
2003-07-31
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Ina Ly, K; Vakulenko-Lagun, Bella; Emblem, Kyrre E et al. (2018) Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Sci Rep 8:17062
Nowak-Sliwinska, Patrycja; Alitalo, Kari; Allen, Elizabeth et al. (2018) Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis 21:425-532
Zhao, Yingchao; Liu, Pinan; Zhang, Na et al. (2018) Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models. Proc Natl Acad Sci U S A 115:E2077-E2084
Hong, Theodore S; Grassberger, Clemens; Yeap, Beow Y et al. (2018) Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy. NPJ Precis Oncol 2:22
Pinter, Matthias; Kwanten, Wilhelmus J; Jain, Rakesh K (2018) Renin-Angiotensin System Inhibitors to Mitigate Cancer Treatment-Related Adverse Events. Clin Cancer Res 24:3803-3812
Arvanitis, Costas D; Askoxylakis, Vasileios; Guo, Yutong et al. (2018) Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption. Proc Natl Acad Sci U S A 115:E8717-E8726
Khandekar, Melin J; Jain, Rakesh (2018) Smooth sailing for immunotherapy for unresectable stage III non-small cell lung cancer: the PACIFIC study. Transl Cancer Res 7:S16-S20
Stylianopoulos, Triantafyllos; Munn, Lance L; Jain, Rakesh K (2018) Reengineering the Tumor Vasculature: Improving Drug Delivery and Efficacy. Trends Cancer 4:258-259
Grassberger, Clemens; Hong, Theodore S; Hato, Tai et al. (2018) Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer. Int J Radiat Oncol Biol Phys 101:1222-1225
Zhang, Na; Chen, Jie; Ferraro, Gino B et al. (2018) Anti-VEGF treatment improves neurological function in tumors of the nervous system. Exp Neurol 299:326-333

Showing the most recent 10 out of 320 publications